Global and Gene-Specific DNA Methylation Analysis in Human Leukemia
Year: 2003
Type: article
Study design: Observational Study
Abstract: Leukemia is a malignant neoplasm of hematopoietic cells characterized by a block in differentiation and a failure to respond to signals that govern normal proliferation and apoptosis.For clinical purposes, leukemias are classified according to the stage of development (acute or chronic) and by cell lineage (lymphoid or myeloid).The pathogenesis of the various forms of leukemia differs, but one thing leukemias have in common with all other cancers is an underlying genetic defect such as chromosomal translocations and other rearrangements, small deletions, amplifications, mutations, or loss or gain of entire chromosomes.Some of these abnormalities are apparent at the cytogenetic level, while others are detected only with molecular techniques.Recurrent chromosomal changes have been known for quite some time.However, in the past decade there has been increasing awareness of the importance of epigenetic alterations in the initiation and progression of cancer.Epigenetic lesions are heritable changes in the DNA that are not caused by changes in the DNA sequence.The field of epigenetics currently involves the study of DNA cytosine methylation and chromatin structure.Chromatin structure is largely dictated by the acetylation state of histones, which affects the ability of transcription factors and DNA binding proteins to access the DNA.DNA methylation is a modification of the number 5 carbon of cytosine, and occurs most often in the context of a CG dinucleotide (CG).While most CGs in the human genome are methylated, dense stretches of unmethylated CGs are congregated in CpG islands, which are frequently located in the 5'region of genes, encompassing the promoter, exon 1, and sometimes extending into intron 1. Aberrant methylation of CpG islands in cancer cells correlates with transcriptional inactivation of the gene, thus resulting in the functional equivalent of a deletion or inactivating mutation.We hypothesized that aberrant methylation plays a role in hematologic malignancies by contributing to the silencing of genes involved in normal growth and differentiation.We tested this by employing a novel methylation analysis technique, Restriction Landmark Genomic Scanning (RLGS), to identify methylated genes in acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL).Chapter 1 presents an overview of what is currently known about aberrant vii
Author: Laura J. Rush
Institution: The Ohio State University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2347193881
